The Role of Telemedicine in Type 1 Diabetes Children during COVID-19 Pandemic Era: A Systematic Review and Meta-analysis

Nur Rochmah; Farahdina Farahdina; Wika Yuli  Deakandi; Qurrota Ayuni Novia  Putri; Tyas Maslakhatien  Nuzula; Katherine  Fedora; Qorri  ‘Aina; Muhammad Faizi

doi:10.3889/oamjms.2023.10097

Authors

Nur Rochmah Department of Child Health, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Hospital, Surabaya, East Java, Indonesia
Farahdina Farahdina Department of Child Health, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Hospital, Surabaya, East Java, Indonesia https://orcid.org/0000-0001-6994-6564
Wika Yuli Deakandi Faculty of Medicine, Universitas Islam Malang, Malang, East Java, Indonesia https://orcid.org/0000-0002-5656-8725
Qurrota Ayuni Novia Putri Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia https://orcid.org/0000-0002-5865-6382
Tyas Maslakhatien Nuzula Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia https://orcid.org/0000-0002-7806-4501
Katherine Fedora Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia https://orcid.org/0000-0003-0857-1230
Qorri ‘Aina Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia https://orcid.org/0000-0002-0500-8787
Muhammad Faizi Department of Child Health, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Hospital, Surabaya, East Java, Indonesia https://orcid.org/0000-0002-9626-9615

DOI:

https://doi.org/10.3889/oamjms.2023.10097

Keywords:

Telemedicine, COVID-19, HbA1c, Physical activity, T1D

Abstract

BACKGROUND: The COVID-19 pandemic determined a profound impact on the routine follow-up of type 1 diabetes (T1D) children. Telemedicine represents a critical tool to guarantee regular care for these patients in this form.

AIM: The purpose of this study was to assess the impact of telemedicine programs during the COVID-19 pandemic era on T1D children.

PATIENTS AND METHODS: Studies from PubMed, Cochrane, and Directory of Open Access Journals from December 2021, to February 18, 2022, were conducted to calculate the pooled mean difference using either a random or fixed-effect model in Review Manager version 5.3. Our study has applied to ensure that our procedures, including record collection, extraction of data, quality evaluation, and statistical analysis, adhere to the Preferred Reporting Items for Systematic Examination and Meta-Analysis guidelines.

RESULTS: Three articles relevant to the current study (436 children). Our pooled analysis found that there was an impact of telemedicine in reducing the HbA1c (mean diff: 5.64 [95% confidence interval (CI) 3.71–7.57], p < 0.00001). However, the physical activity was not affected by the telemedicine program (mean diff: −37.25 [95% CI −317.53–243.02], p = 0.79).

CONCLUSION: Our findings suggest that telemedicine has a role in T1D children controlling HbA1c during the COVID-19 pandemic. Meanwhile, telehealth has emerged as a promising alternate mode of health-care delivery. Its utility during the pandemic warrants further investigation.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Sussman M, Benner J, Haller MJ, Rewers M, Griffiths R. Estimated lifetime economic burden of Type 1 diabetes. Diabetes Technol Ther. 2020;22(2):121-30. https://doi.org/10.1089/dia.2019.0398 PMid:31886730 DOI: https://doi.org/10.1089/dia.2019.0398

Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Fard HH, Ghojazadeh M. Prevalence and incidence of Type 1 diabetes in the world: A systematic review and meta-analysis. Health Promot Perspect. 2020;10(2):98-115. https://doi.org/10.34172/hpp.2020.18 PMid:32296622. DOI: https://doi.org/10.34172/hpp.2020.18

Subramanian S, Baidal D. The management of Type 1 diabetes. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, et al, editors. Endotext. South Dartmouth, MA: MDText.com, Inc.; 2000. Available from: https://www.ncbi.nlm.nih.gov/books/nbk279114 [Last accessed on 2022 Mar 11].

Lucier J, Weinstock RS. Diabetes mellitus Type 1. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/nbk507713 [Last accessed on 2022 Mar 11].

Feltbower RG, Bodansky HJ, Patterson CC, Parslow RC, Stephenson CR, Reynolds C, et al. Acute complications and drug misuse are important causes of death for children and young adults with Type 1 diabetes: Results from the Yorkshire register of diabetes in children and young adults. Diabetes Care. 2008;31(5):922-6. https://doi.org/10.2337/dc07-2029 PMid:18285550 DOI: https://doi.org/10.2337/dc07-2029

DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018;391(10138):2449-62. https://doi.org/10.1016/ S0140-6736(18)31320-5 PMid:29916386 DOI: https://doi.org/10.1016/S0140-6736(18)31320-5

Virk SA, Donaghue KC, Cho YH, Benitez-Aguirre P, Hing S, Pryke A, et al. Association between HbA1c variability and risk of microvascular complications in adolescents with Type 1 diabetes. J Clin Endocrinol Metab. 2016;101(9):3257-63. https://doi.org/10.1210/jc.2015-3604 PMid:27186858 DOI: https://doi.org/10.1210/jc.2015-3604

Bergenstal RM. Glycemic variability and diabetes complications: Does it matter? Simply put, there are better glycemic markers! Diabetes Care. 2015;38(8):1615-21. https://doi.org/10.2337/dc15-0099 PMid:26207055 DOI: https://doi.org/10.2337/dc15-0099

Núñez A, Sreeganga SD, Ramaprasad A. Access to healthcare during COVID-19. Int J Environ Res Public Health. 2021;18(6):2980. https://doi.org/10.3390/ijerph18062980 PMid:33799417 DOI: https://doi.org/10.3390/ijerph18062980

Mannelli C. Whose life to save? Scarce resources allocation in the COVID-19 outbreak. J Med Ethics. 2020;46(6):364-6. https://doi.org/10.1136/medethics-2020-106227 PMid:32277018 DOI: https://doi.org/10.1136/medethics-2020-106227

Xu T, Pujara S, Sutton S, Rhee M. Telemedicine in the management of Type 1 diabetes. Prev Chronic Dis. 2018;15(1):E13. https://doi.org/10.5888/pcd15.170168 PMid:29369757 DOI: https://doi.org/10.5888/pcd15.170168

Hartley D. Rural health disparities, population health, and rural culture. Am J Public Health. 2004;94(10):1675-8. https://doi.org/10.2105/ajph.94.10.1675 PMid:15451729 DOI: https://doi.org/10.2105/AJPH.94.10.1675

Alexandra S, Handayani PW, Azzahro F. Indonesian hospital telemedicine acceptance model: The influence of user behavior and technological dimensions. Heliyon. 2021;7(12):e08599. https://doi.org/10.1016/jheliyon.2021.e08599 PMid:34977414 DOI: https://doi.org/10.1016/j.heliyon.2021.e08599

World Health Organization. Telemedicine: Opportunities and Developments in Member States. Report on the Second Global Survey on eHealth. Geneva: World Health Organization; 2010. p. 93.

Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ (Online). 2009;339:b2535. https://doi.org/10.1136/bmj.b2535 PMid:19622551 DOI: https://doi.org/10.1136/bmj.b2535

Odeh R, Gharaibeh L, Daher A, Kussad S, Alassaf A. Caring for a child with Type 1 diabetes during COVID-19 lockdown in a developing country: Challenges and parents’ perspectives on the use of telemedicine. Diabetes Res Clin Pract. 2020;168:108393. https://doi.org/10.1016/j.diabres.2020.108393 PMid:32858098 DOI: https://doi.org/10.1016/j.diabres.2020.108393

Lazzeroni P, Motta M, Monaco S, Laudisio SR, Furoncoli D, Maffini V, et al. Improvement in glycaemic control in paediatric and young adult Type 1 diabetes patients during COVID-19 pandemic: Role of telemedicine and lifestyle changes. Acta Biomed. 2021;92(5):e2021399. https://doi.org/10.23750/abm.v92i5.11911 PMid:34738562

Predieri B, Leo F, Candia F, Lucaccioni L, Madeo SF, Pugliese M, et al. Glycemic control improvement in Italian children and adolescents with Type 1 diabetes followed through telemedicine during lockdown due to the COVID-19 pandemic. Front Endocrinol (Lausanne). 2020;11:595735. https://doi.org/10.3389/fendo.2020.595735 PMid:33424771 DOI: https://doi.org/10.3389/fendo.2020.595735

Christoforidis A, Kavoura E, Nemtsa A, Pappa K, Dimitriadou M.

Coronavirus lockdown effect on Type 1 diabetes management οn children wearing insulin pump equipped with continuous glucose monitoring system. Diabetes Res Clin Pract. 2020;166:108307. https://doi.org/10.1016/j.diabres.2020.108307 PMid:32650036 DOI: https://doi.org/10.1016/j.diabres.2020.108307

Jendle JH, Riddell MC. Editorial: Physical activity and Type 1 diabetes. Front Endocrinol (Lausanne). 2019;10:860. https://doi.org/10.3389/fendo.2019.00860 PMid:31866952 DOI: https://doi.org/10.3389/fendo.2019.00860

Houlder SK, Yardley JE. Continuous glucose monitoring and exercise in Type 1 diabetes: Past, present and future. Biosensors (Basel). 2018;8(3):73. https://doi.org/10.3390/bios8030073 PMid:30081478 DOI: https://doi.org/10.3390/bios8030073

Tornese G, Ceconi V, Monasta L, Carletti C, Faleschini E, Barbi E. Glycemic control in Type 1 diabetes mellitus during COVID-19 quarantine and the role of in-home physical activity. Diabetes Technol Ther. 2020;22(6):462-7. https://doi.org/10.1089/dia.2020.0169 PMid:32421355 DOI: https://doi.org/10.1089/dia.2020.0169

Elhenawy YI, Eltonbary KY. Glycemic control among children and adolescents with Type 1 diabetes during COVID-19 pandemic in Egypt: A pilot study. Int J Diabetes Dev Ctries. 2021;41(3):389-95. https://doi.org/10.1007/s13410-021-00968-y PMid:34257483 DOI: https://doi.org/10.1007/s13410-021-00968-y